Skip to content
10-Q

Quarterly Report

Allogene Therapeutics, Inc. ALLO

0001628280-25-050230

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 224.73M sh
Shares Diluted Q3 2025 · Sep 30, 2025 222.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 218.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 209.19M sh
Shares Diluted Q3 2025 · Sep 30, 2024 189.52M sh
Capex Q3 2025 · Sep 30, 2025 $386K
Capex Q3 2025 · Sep 30, 2024 $437K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$121.65M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$163.6M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $37.82M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $75.22M
Stockholders Equity Q3 2025 · Sep 30, 2025 $315.33M
Stockholders Equity Q3 2025 · Jun 30, 2025 $344.56M
Stockholders Equity Q3 2025 · Mar 31, 2025 $385.39M
Stockholders Equity Q3 2025 · Dec 31, 2024 $422.18M
Stockholders Equity Q3 2025 · Sep 30, 2024 $463.75M
Stockholders Equity Q3 2025 · Jun 30, 2024 $515.04M
Stockholders Equity Q3 2025 · Mar 31, 2024 $461.37M
Stockholders Equity Q3 2025 · Dec 31, 2023 $512.23M
Current Liabilities Q3 2025 · Sep 30, 2025 $31.83M
Current Liabilities Q3 2025 · Dec 31, 2024 $35.52M
Total Liabilities Q3 2025 · Sep 30, 2025 $124.44M
Total Liabilities Q3 2025 · Dec 31, 2024 $126.53M
Current Assets Q3 2025 · Sep 30, 2025 $260.72M
Current Assets Q3 2025 · Dec 31, 2024 $303.39M
Total Assets Q3 2025 · Sep 30, 2025 $439.77M
Total Assets Q3 2025 · Dec 31, 2024 $548.71M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.19
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.70
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.70
Eps Basic Q3 2025 · Sep 30, 2024 −$0.32
Eps Basic Q3 2025 · Sep 30, 2024 −$1.04
Sga Expense Q3 2025 · Sep 30, 2025 $13.74M
Sga Expense Q3 2025 · Sep 30, 2025 $43.01M
Sga Expense Q3 2025 · Sep 30, 2024 $16.33M
Sga Expense Q3 2025 · Sep 30, 2024 $49.69M
Rd Expense Q3 2025 · Sep 30, 2025 $31.16M
Rd Expense Q3 2025 · Sep 30, 2025 $121.52M
Rd Expense Q3 2025 · Sep 30, 2024 $44.71M
Rd Expense Q3 2025 · Sep 30, 2024 $147.33M
Net Income Q3 2025 · Sep 30, 2025 −$41.4M
Net Income Q3 2025 · Sep 30, 2025 −$152.08M
Net Income Q3 2025 · Jun 30, 2025 −$50.94M
Net Income Q3 2025 · Mar 31, 2025 −$59.73M
Net Income Q3 2025 · Sep 30, 2024 −$66.29M
Net Income Q3 2025 · Sep 30, 2024 −$197.65M
Net Income Q3 2025 · Jun 30, 2024 −$66.36M
Net Income Q3 2025 · Mar 31, 2024 −$65M
Operating Income Q3 2025 · Sep 30, 2025 −$44.9M
Operating Income Q3 2025 · Sep 30, 2025 −$166.91M
Operating Income Q3 2025 · Sep 30, 2024 −$71.77M
Operating Income Q3 2025 · Sep 30, 2024 −$212.71M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $22K